Increased disease severity and mortality associated with the Bronchiectasis-GORD phenotype

Melissa McDonnell (Galway, Ireland), Melissa McDonnell, O’Mahony Michael, Breen David, O’Regan Anthony, Rutherford Robert

Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Session: Bronchiectasis and NTM infections: clinical aspects and research outlook
Session type: Poster Discussion
Number: 366
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Melissa McDonnell (Galway, Ireland), Melissa McDonnell, O’Mahony Michael, Breen David, O’Regan Anthony, Rutherford Robert. Increased disease severity and mortality associated with the Bronchiectasis-GORD phenotype. Eur Respir J 2015; 46: Suppl. 59, 366

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Thrombocytosis is associated with disease severity and outcomes in stable bronchiectasis
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015


Impact of co-morbidities on disease severity and risk of mortality in non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015


Presence of aspiration pneumonia is independently associated with mortality, after adjusting for age, disease severity, and comorbities
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013

Coagulation activity increases with disease severity in patients with asthma
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015

Risk factors for chronic pulmonary aspergillosis in a low prevalence country and their effect on survival
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015

Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation?
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014

Bronchiectasis in patients with alpha1-antitrypsin deficiency: prevalence and characteristics
Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments
Year: 2016


Systemic inflammation, comorbidities and the outcome of adult-onset asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015


Late Breaking Abstract - Dysbiosis in the lung microbiome of patients with HIV and pneumonia is associated with worse disease severity and mortality scores
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021



Mortality and survival predictor in chronic hypersensitivity pneumonitis
Source: International Congress 2016 – Sarcoidosis
Year: 2016

Metabolic syndrome in patients with COPD and their association with systemic inflammation
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015


Bronchiectasis is common in severe asthma
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016


Abnormal heart rate variability in patients with bronchiectasis
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015


Anaemia in COPD: mortality and disease severity
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007


Obesity influences inflammatory phenotype mainly in early onset severe asthmatics
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014

Mortality in COPD: role of comorbidities
Source: Eur Respir J 2006; 28: 1245-1257
Year: 2006



Determinants and assessment of excess cardiovascular risk in bronchiectasis
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015



Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013

Factors contributing to severe pneumonia in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014


Lung function impairment in adult asthma increases the risk of systemic inflammation
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015